Advertisement

Index by author

October 01, 1995; Volume 275,Issue 1

  1. Samuelsson, B

    1. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
      A Wetterholm, J Z Haeggström, B Samuelsson, W Yuan, B Munoz and C H Wong
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 31-37;

  2. Sandor, Z

    1. Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats.
      S Kusstatscher, Z Sandor, S Szabo, A Seddon and P Böhlen
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 456-461;

  3. Sannerud, C A

    1. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
      C A Sannerud and N A Ator
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 183-193;

  4. Sato, Y

    1. Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.
      T Aizawa, N Taguchi, Y Sato, T Nakabayashi, H Kobuchi, H Hidaka, T Nagasawa, F Ishihara, N Itoh and K Hashizume
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 194-199;

  5. Sawa, T

    1. Arachidonic acid cascade and stimulation of acetylcholine release by human recombinant interleukin-1 beta in guinea pig ileum.
      S Mameya, T Sawa and K Taniyama
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 319-324;

  6. Sawynok, J

    1. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
      C M Cahill, T D White and J Sawynok
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 84-93;

  7. Schiller, P

    1. Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
      T L Yaksh, A B Malmberg, S Ro, P Schiller and M Goodman
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 63-72;

  8. Schmidt, A W

    1. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
      T F Seeger, P A Seymour, A W Schmidt, S H Zorn, D W Schulz, L A Lebel, S McLean, V Guanowsky, H R Howard and J A Lowe
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 101-113;

  9. Schor, N F

    1. Induction of apoptosis in murine and human neuroblastoma cell lines by the enediyne natural product neocarzinostatin.
      T L Hartsell, J C Yalowich, M K Ritke, A J Martinez and N F Schor
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 479-485;

  10. Schulz, D W

    1. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
      T F Seeger, P A Seymour, A W Schmidt, S H Zorn, D W Schulz, L A Lebel, S McLean, V Guanowsky, H R Howard and J A Lowe
      Journal of Pharmacology and Experimental Therapeutics October 1995, 275 (1) 101-113;
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement